The combination of PT3 and FUC in our study suggests a promising approach for cancer treatment, as both compounds appear to act synergistically to increase apoptosis in TIB-223 and Caco2 cells, similar to the findings previously reported for hepatocarcinoma and breast cancer cells [28,62,63,64]. The gene discussed is ZNF135; the disease is breast carcinoma.